Ra Capital Management, L.P. Sutro Biopharma, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $38.2 Million - $50.5 Million	-2,118,212 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $1.48 Million - $2.61 Million	198,568 Added 10.34%	2,118,212 $21.3 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $13.9 Million - $21.2 Million	1,919,644 New	1,919,644 $14.9 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $97.5M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.